Latest filing published 04 Feb 2015 for CENTENE CORP, €42k.
No signal scores available.
Jason M. Harrold discloses dealings in 2 companies, chiefly Centene Corp and Opticare Health Systems Inc. Over a trading history stretching from 6 March 2006 to 3 February 2015, the count stands at 46 filings.
Sales make up the whole of the open-market record (5 sales, €774k). Outside the open market, there are 39 share grants and 1 option exercise.
The record was last updated on 4 February 2015 with a share grant (€42k) in Centene Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 41 declarations